Progressing From Metformin to Sulfonylureas or Meglitinides
- PMID: 27621259
- DOI: 10.1177/2165079916644263
Progressing From Metformin to Sulfonylureas or Meglitinides
Abstract
The article provides an overview of sulfonylureas and meglitinides as second-line agents for treating type 2 diabetes mellitus (T2DM). Implications for occupational health clinicians who work with these individuals when they take either of these medications to achieve target glycemic indices are emphasized.
Keywords: meglitinides; metformin; sulfonylureas; type 2 diabetes mellitus.
© 2016 The Author(s).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
